2. Search Result
Search Result
Results for "

1983983-41-0

" in MedChemExpress (MCE) Product Catalog:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-137432
    Avotaciclib
    1 Publications Verification

    BEY1107

    		 CDK Cancer
    Avotaciclib (BEY1107) is a potent and orally active inhibitor of cyclin dependent kinase 1 (CDK1). Avotaciclib can be used for the research of locally advanced or metastatic pancreatic cancer .
    Avotaciclib
  • HY-137432B
    Avotaciclib hydrochloride
    1 Publications Verification

    BEY1107 hydrochloride

    		 CDK Cancer
    Avotaciclib hydrochloride is the hydrochloride form of Avotaciclib (HY-137432), a CDK1 inhibitor. Avotaciclib hydrochloride can be used for a few specific cancers, such as pancreatic cancer, in which CDK1 is abnormal and strongly expressed .
    Avotaciclib hydrochloride
  • HY-137432A
    Avotaciclib trihydrochloride
    1 Publications Verification

    BEY1107 trihydrochloride

    		 CDK Cancer
    Avotaciclib (BEY1107) trihydrochloride is a potent and orally active inhibitor of cyclin dependent kinase 1 (CDK1). Avotaciclib trihydrochloride can be used for the research of locally advanced or metastatic pancreatic cancer .
    Avotaciclib trihydrochloride
  • HY-137432D
    Avotaciclib sulfate

    BEY1107 sulfate

    		 CDK Cancer
    Avotaciclib (BEY1107) sulfate is a potent and orally active inhibitor of cyclin dependent kinase 1 (CDK1). Avotaciclib sulfate can be used for the research of locally advanced or metastatic pancreatic cancer .
    Avotaciclib sulfate

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: